Panacea Innovation Ltd - 16 Dec 2025 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
Panacea Innovation Ltd
Reporting Manager
James Huang
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
20,673,453 shares
Disclosed Ownership
4,651,527 shares
Ownership
22.5%
Form type
SCHEDULE 13D/A
Filing time
17 Dec 2025, 16:15:02 UTC
Date of event
16 Dec 2025
Previous filing
26 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 22% 4,529,956 0 4,529,956 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner 0001869939
Panacea Venture Healthcare Fund II GP Company, Ltd. 22% 4,529,956 0 4,529,956 By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 22% 4,529,956 0 4,529,956 /s/ James Huang James Huang, Founding Managing Partner 0002010692
James Huang 22.5% 4,651,527 121,571 4,529,956 /s/ James Huang James Huang 0001573160